Mantle cell lymphoma is a rare form of B-cell non-Hodgkin lymphoma. It is a type of blood cancer that affects white blood cells called lymphocytes.
Mantle cell lymphoma (MCL) is a rare form of B-cell non-Hodgkin lymphoma (NHL). It is a type of blood cancer that affects white blood cells called lymphocytes. Lymphocytes are white blood cells which help fight infections and other diseases in the body. The disease gets its name because it affects lymphocytes in the mantle zone of a lymph node. Lymphocytes are found mostly in the lymphatic system, which includes lymph nodes, spleen, and bone marrow.
Read Report Overview - https://www.transparencymarketresearch.com/mantle-cell-lymphoma-treatment-market.html
MCL cells can spread to other lymph nodes or tissues, such as the gastrointestinal tract, liver, and marrow. A study published by the Leukemia and Lymphoma Society revealed that about 70,800 new cases of NHL were reported in the U.S. in 2014, with only 6% cases (about 4,200) of MCL. It is diagnosed more often in men than women. Caucasian men and women are at a higher risk than men and women of color.
MCL occurs mostly in older population and the average age in which cases are diagnosed is mid-60s. Common symptoms of the disease include abdominal pain or bloating, fever, loss of appetite & weight loss, nausea and/or vomiting, night sweats, indigestion, and feeling discomfort. The type of treatment for a patient suffering from MCL depends on various factors such as age, overall health of the patient, and disease stage.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58917
The global mantle cell lymphoma treatment market is projected to grow at a rapid pace in the next few years due to rise in the number of people suffering from mantle cell lymphoma and increase in research and development activities in the health care sector resulting in a favorable product pipeline. A study published in Cancer Journal for Clinicians indicated that 3,320 new cases of MCL were diagnosed in the U.S. in 2016. Approvals for various new drugs by federal agencies is expected to drive the global mantle cell lymphoma treatment market.
For instance, in May 2018, the FDA approved AstraZeneca’s Calquence (Acalabrutinib) for relapsed or refractory mantle-cell lymphoma in adults. The mantle cell lymphoma treatment market is also driven by development of targeted therapy drugs with low toxicity in combination with approved drugs for the treatment of relapsed mantle cell lymphoma. However, side effects of these drugs such as neutropenia, anemia, and diarrhea are likely to restrain the global mantle cell lymphoma treatment market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=58917
The global mantle cell lymphoma treatment market can be segmented based on type of therapy, route of administration, end-user, and region. In terms of type of therapy, the mantle cell lymphoma treatment market can be categorized into targeted therapy, chemotherapy, biologics, and radiotherapy. Based on route of administration, the global mantle cell lymphoma treatment market can be bifurcated into oral and intravenous. In terms of end-user, the mantle cell lymphoma treatment market can be divided into hospitals and clinics.
Based on region, the global mantle cell lymphoma treatment market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is projected to lead the global mantle cell lymphoma treatment market during the forecast period. The region’s dominance is attributed to rise in prevalence of mantle cell lymphomas and increase in health care awareness among people about early diagnosis.
Pre Book Mantle Cell Lymphoma Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=58917<ype=S
Moreover, the FDA is focusing on rare diseases, including mantle cell lymphoma, by granting accelerated approvals, breakthrough designations, and orphan drug designations to make treatments available for patients with rare diseases. Asia Pacific and Europe are expected to be the other major markets owing to increase in government initiatives and rise in research and development activities.
Key players operating in the global mantle cell lymphoma treatment market include Bristol-Myers Squibb, GlaxoSmithKline plc, Amgen, Inc., Celgene Corporation, Eli Lilly and Company, AbbVie, Inc., F. Hoffmann-La Roche AG, Bayer AG, Kite Pharma (Gilead Sciences, Inc.), and Johnson & Johnson.
Browse more Reports by Transparency Market Research:
Cell Based Assays Market: The global cell based assays market is driven progressively by the extensive utilization of the techniques in new drugs developments by pharmaceutical companies. The applications are eminently reinforced by quickly rising number of medications for deadly ailments in various regions of the world.
Melanoma Therapeutics Market: The global melanoma therapeutics market is expected to be driven by the rising cases of melanoma and many other types of skin cancers. Cancer-related to skin is of three different types, which are melanoma, squamous cell carcinoma, and basal cell carcinoma.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/